Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia
NCT06353698 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-04-09
Summary
The goal of this clinical trial is to investigate The effect of fasting mimicking diet with chemotherapy on the number of blasts and platelets and quality of life in patients with acute lymphoid leukemia and acute myeloid leukemia.
Conditions
- Fasting Mimicking Diet
- Leukemia
Interventions
- DIETARY_SUPPLEMENT
-
fasting mimicking diet
Fasting mimicking diet is limited calorie diet to enhance the effectiveness of chemotherapy
Sponsors & Collaborators
-
National Nutrition and Food Technology Institute
lead OTHER
Principal Investigators
-
Ehsan Hejazi, PhD · Beheshti University of Medical Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-02
- Primary Completion
- 2024-04-01
- Completion
- 2024-05-01
Countries
- Iran
Study Locations
More Related Trials
-
Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer
NCT05283616 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients
NCT05221593 ·Status: COMPLETED ·Phase: PHASE3
-
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
NCT00416624 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy
NCT02944604 ·Status: COMPLETED ·Phase: PHASE4
-
Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions
NCT00602134 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer
NCT04009941 ·Status: COMPLETED ·Phase: PHASE4
-
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies
NCT00036023 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
NCT02905916 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients
NCT01637493 ·Status: UNKNOWN ·Phase: PHASE1
-
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
NCT03618810 ·Status: UNKNOWN
-
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
NCT00726934 ·Status: COMPLETED ·Phase: NA
-
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
NCT00661999 ·Status: COMPLETED ·Phase: PHASE3
-
Profiling Neutrophil Counts in Patients on Chemotherapy
NCT02806557 ·Status: UNKNOWN
-
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
NCT07096479 ·Status: RECRUITING
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients
NCT01238562 ·Status: COMPLETED ·Phase: PHASE1
-
Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia
NCT00212862 ·Status: COMPLETED
-
Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients
NCT03376503 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 ·Status: COMPLETED
-
A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy
NCT01285219 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia
NCT05851027 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia
NCT02805205 ·Status: COMPLETED ·Phase: PHASE4
-
Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions
NCT01697020 ·Status: COMPLETED ·Phase: PHASE1
-
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)
NCT00114764 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
NCT06521931 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy
NCT00272662 ·Status: COMPLETED ·Phase: PHASE2